Joshua Davis

Menzies School of Health Research

Accepting PhD Students

20032019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Joshua Davis is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 31 Similar Profiles
Northern Territory Medicine & Life Sciences
Sepsis Medicine & Life Sciences
Anti-Bacterial Agents Medicine & Life Sciences
Infection Medicine & Life Sciences
Lactams Medicine & Life Sciences
Methicillin-Resistant Staphylococcus aureus Medicine & Life Sciences
Randomized Controlled Trials Medicine & Life Sciences
Staphylococcus aureus Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2003 2019

Adjunctive protein synthesis inhibitor antibiotics for toxin suppression in Staphylococcus aureus infections: a systematic appraisal

Campbell, A. J., Dotel, R., Blyth, C. C., Davis, J. S., Tong, S. Y. C. & Bowen, A. C., 1 Jan 2019, In : The Journal of antimicrobial chemotherapy. 74, 1, p. 1-5 5 p.

Research output: Contribution to journalArticleResearchpeer-review

Protein Synthesis Inhibitors
Staphylococcus aureus
Anti-Bacterial Agents
Exotoxins
Infection

A protocol for a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis: BLING III

Lipman, J., Brett, S. J., De Waele, J. J., Cotta, M. O., Davis, J. S., Finfer, S., Glass, P., Knowles, S., McGuinness, S., Myburgh, J., Paterson, D. L., Peake, S., Rajbhandari, D., Rhodes, A., Roberts, J. A., Shirwadkar, C., Starr, T., Taylor, C., Billot, L. & Dulhunty, J. M., 1 Mar 2019, In : Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine. 21, 1, p. 63-68 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Lactams
Critical Illness
Sepsis
Randomized Controlled Trials
Random Allocation

CASSETTE-clindamycin adjunctive therapy for severe Staphylococcus aureus treatment evaluation: Study protocol for a randomised controlled trial

Dotel, R., Tong, S. Y. C., Bowen, A., Nelson, J. N., O'sullivan, M. V. N., Campbell, A. J., McMullan, B. J., Britton, P. N., Francis, J. R., Eisen, D. P., Robinson, O., Manning, L. & Davis, J. S., 13 Jun 2019, In : Trials. 20, 1, p. 1-13 13 p., 353.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
Clindamycin
Staphylococcus aureus
Randomized Controlled Trials
Exotoxins
Infection
1 Downloads (Pure)

Cefazolin versus anti-staphylococcal penicillins for the treatment of patients with Staphylococcus aureus bacteraemia

Weis, S., Kesselmeier, M., Davis, J. S., Morris, A. M., Lee, S., Scherag, A., Hagel, S. & Pletz, M. W., Jul 2019, In : Clinical Microbiology and Infection. 25, 7, p. 818-827 10 p.

Research output: Contribution to journalReview articleResearchpeer-review

Open Access
File
Cefazolin
Bacteremia
Penicillins
Staphylococcus aureus
Methicillin

Duration of therapy recommended for bacteraemic illness varies widely amongst clinicians

Alwan, M., Davis, J. S., Daneman, N., Fowler, R., Shehabi, Y. & Rogers, B., 11 May 2019, In : International Journal of Antimicrobial Agents. p. 1-5 5 p.

Research output: Contribution to journalArticleResearchpeer-review

Communicable Diseases
Therapeutics
Anti-Bacterial Agents
Physicians
New Zealand